Automated Cell Shakers Market to Grow with a CAGR of 7.08% through 2030
Advancements
in shaker technology for improved temperature and agitation control and the
rising focus on scalable cell-based workflows, is expected to
drive the Global Automated Cell Shakers Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “Automated Cell Shakers Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2030F”,
the Global Automated Cell Shakers Market stood at USD 701.21 Million in
2024 and is expected to reach USD 1058.56 Million by 2030 with a CAGR of 7.08% during
the forecast period. The
Global Automated Cell Shakers Market is progressing due to increasing reliance
on automation in biotechnology research and biologics development. These
systems enable hands-free, uniform mixing of cultures, making them essential in
environments where precision and scalability are key. The rise in complex
biologic drug pipelines, demand for monoclonal antibodies, and the need for
consistent culture conditions across multiple batches is encouraging the
adoption of high-throughput automated shakers. Pharmaceutical and biotech firms
are seeking ways to reduce manual interventions in cell-based experiments,
minimizing human error and ensuring data accuracy. Growth in laboratory
digitization and process optimization initiatives across private and academic
institutions has further accelerated investment in next-gen automated shakers
tailored to dynamic research needs.
Technological
evolution in automated shaking systems is now focused on intelligence,
adaptability, and integration. Compact designs with low noise and vibration,
compatibility with robotic arms, and motion versatility (orbital, linear, or
reciprocal shaking) are redefining product design. Enhanced temperature
regulation, multi-zone heating capabilities, and precision humidity control are
improving culture viability across various protocols. Real-time synchronization
with laboratory information management systems (LIMS) is becoming standard,
allowing continuous data collection and automated alerts for deviations. Demand
for flexible systems that support a wide range of vessel types from microplates
to large flasks is fostering modularity in product offerings. Leading
manufacturers are embedding predictive diagnostics and fail-safe operations
that ensure uninterrupted productivity even in high-load environments.
The
market presents significant untapped growth opportunities, especially through
expanding applications in stem cell research, tissue engineering, and cell
therapy manufacturing. Collaborations with contract research and manufacturing
organizations can accelerate deployment in fast-paced R&D and pilot-scale
facilities. Offering cloud-enabled monitoring dashboards, AI-driven
optimization suggestions, and on-demand remote technical support can appeal to
research teams seeking smart lab ecosystems. Custom solutions for niche
applications such as 3D culture agitation or virus production can open
specialized revenue streams. As sustainability becomes a competitive
differentiator, designing energy-efficient shakers with biodegradable
components or renewable power integration can attract environmentally driven
customers. Emerging markets, with their rising biotech footprints and
government-backed innovation funding, also represent fertile ground for
manufacturers aiming to scale adoption of automated cell shaking systems.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Automated Cell Shakers Market”
The Global Automated
Cell Shakers Market is segmented into product, application, end user, regional
distribution, and company.
Based on the Application,
Regenerative Medicine emerged as the fastest growing segment in the Global Automated
Cell Shakers Market during the forecast period. This is driven by the increasing global focus on
advanced therapies such as stem cell therapy, tissue engineering, and
cell-based gene therapies. Regenerative medicine applications require precise
and reproducible culture conditions to maintain cell viability, differentiation
potential, and functionality making automated cell shakers indispensable for
research and production workflows. These systems provide controlled agitation
and optimal environmental conditions that support the expansion and scaling of
delicate cell types such as human pluripotent stem cells and mesenchymal stem
cells.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Automated Cell Shakers Market during
the forecast period. This is due to the manufacturing expansion, academic and
research institutions in Asia-Pacific are increasingly integrating automation
into their laboratories to enhance research output and align with international
benchmarks. Funding for life sciences research from both public and private
sectors is on the rise, especially in areas like oncology, regenerative
medicine, and infectious disease research. This trend is creating new
opportunities for the use of automated cell shakers in experimental workflows
requiring high precision and reproducibility. The emergence of local laboratory
equipment manufacturers offering region-specific, affordable solutions is
making advanced cell shaking technology more accessible to mid-sized labs and
universities. Moreover, rising awareness of the benefits of laboratory
automation, such as reduced labor, minimized contamination, and improved
process control, is driving a cultural shift in laboratory operations across
the region.
Major
companies operating in Global Automated Cell Shakers Market are:
- Thermo
Fisher Scientific Inc.
- Eppendorf
AG
- Ohaus
Corporation
- Benchmark
Scientific
- Corning
Incorporated
- Grant
Instruments
- Kuhner
Shaker
- Infors
AG
- Boekel
Scientific
- VELP
Scientifica Srl
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global Automated Cell Shakers Market
is expanding due to the increasing demand for high-throughput and
contamination-free cell culture systems in the development of cell and gene
therapies. These therapies require precise environmental control, reproducibility,
and scalability to ensure consistent cell viability and functionality from
research through to clinical manufacturing. Automated cell shakers enable
standardized mixing, minimize human error, and support GMP-compliant
operations, making them critical tools in advanced therapeutic workflows. As
more biopharmaceutical companies and research institutions focus on
commercializing personalized treatments, the adoption of automated solutions
for upstream processing is accelerating rapidly.,” said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Automated Cell Shakers
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
Segmented By Product (Automated Cell Shakers, Orbital Shakers, Benchtop
Incubator Shakers, Cell Shaker with Rotatory Arms, Accessories, Others), By
Application (Drug Development, Regenerative Medicine, Cell Therapy, Stem Cell
Research), By End User (Pharmaceutical Companies, Biopharmaceutical Companies,
CDMOs & CMOs, Hospitals, Others), By Region and Competition, 2020-2030F”,
has evaluated the future growth potential of Global Automated Cell Shakers
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Automated Cell
Shakers Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com